Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH

Suzhou Ribo Life Science Co., Ltd. China Sweden New York

View original content:https://www.prnewswire.co.uk/news-releases/ribo-and-ribocure-announce-exclusive-global-licensing-agreement-with-madrigal-for-novel-sirna-therapeutics-targeting-mash-302685038.html